NIH has $144m to fund cancer nanotech R&D

Dr. Andrew von Eschenbach

Courtesy of National Cancer Institute

The National Cancer Institute plans to devote $144.3 million to a five-year initiative to develop and apply nanotechnology to cancer research.

'Nanotechnology has the potential to radically increase our options for prevention, diagnosis and treatment of cancer,' said Dr. Andrew von Eschenbach, director of the National Institutes of Health agency.

Nanotechnology, the development and engineering of devices so small they are measured on a molecular scale, has already demonstrated promising results in cancer research and treatment, he said.

NIH plans that the initiative, the NCI Alliance for Nanotechnology in Cancer, will integrate cancer-related nanotechnology research from public and private organizations and accelerate its application in clinical practice.

The National Cancer Institute will work with the National Institute of Standards and Technology to collaborate on standards and with the Food and Drug Administration to define the critical pathway for nanotechnologies to reach the clinic.

About the Author

Mary Mosquera is a reporter for Federal Computer Week.


  • Records management: Look beyond the NARA mandates

    Pandemic tests electronic records management

    Between the rush enable more virtual collaboration, stalled digitization of archived records and managing records that reside in datasets, records management executives are sorting through new challenges.

  • boy learning at home (Travelpixs/

    Tucson’s community wireless bridges the digital divide

    The city built cell sites at government-owned facilities such as fire departments and libraries that were already connected to Tucson’s existing fiber backbone.

Stay Connected